首页 > 最新文献

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko最新文献

英文 中文
[Mystery of the illness of the great painter I. Repin. By the 180th anniversary].
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/neiro2025890116
A V Gorozhanin, A G Fedyakov, V E Lovyagina

There was the 180th anniversary of Ilya Yefimovich Repin on August 5, 2024. He is the greatest Russian realist artist of the XIX century, a master of historical and genre painting, as well as outstanding portraitist. Repin's biography is unique. He was a professor and then academician of the Imperial Academy of Arts, teacher, author of memoirs and essays on fine art. After the age of 40, the artist developed a disease with impaired function of the right hand. Therefore, he retrained to write with his left hand. Accurate lifetime and post-mortem diagnosis was not established. The appearance of the artist's right hand represented by posthumous plaster cast indicates neuropathy of the right ulnar nerve.

{"title":"[Mystery of the illness of the great painter I. Repin. By the 180th anniversary].","authors":"A V Gorozhanin, A G Fedyakov, V E Lovyagina","doi":"10.17116/neiro2025890116","DOIUrl":"https://doi.org/10.17116/neiro2025890116","url":null,"abstract":"<p><p>There was the 180<sup>th</sup> anniversary of Ilya Yefimovich Repin on August 5, 2024. He is the greatest Russian realist artist of the XIX century, a master of historical and genre painting, as well as outstanding portraitist. Repin's biography is unique. He was a professor and then academician of the Imperial Academy of Arts, teacher, author of memoirs and essays on fine art. After the age of 40, the artist developed a disease with impaired function of the right hand. Therefore, he retrained to write with his left hand. Accurate lifetime and post-mortem diagnosis was not established. The appearance of the artist's right hand represented by posthumous plaster cast indicates neuropathy of the right ulnar nerve.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":"89 1","pages":"6-10"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Surgical treatment of intramedullary spinal cord tumors: a systematic review]. [髓内脊髓肿瘤的手术治疗:系统回顾]。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/neiro202589011103
N A Konovalov, R A Onoprienko, S V Kaprovoy, E S Brinyuk, B A Zakirov, Yu M Poluektov, S V Ivanov, M O Kudymets, N O Ilyinsky

Background: Intramedullary spinal cord tumors are a rare group of central nervous system tumors with special treatment approaches. The main problems are related to optimal time of surgery, invasiveness and recurrence of tumor.

Objective: To review available literature data on the treatment of intramedullary spinal cord tumors, to summarize the main achievements and changes in treatment strategy over the past 5 years.

Material and methods: We reviewed Russian- and English-language literature on the treatment of intramedullary spinal cord tumors over the past five years. The studies were selected in accordance with PRISMA recommendations.

Results: We analyzed literature data in the PubMed, eLibrary, Cochrane and Medline databases over the last 5 years. The studies were selected taking into account the relevance and quality of researches.

Conclusion: Large-scale studies are rare due to rarity of intramedullary spinal cord tumors. The main changes in surgery for intramedullary spinal cord tumors in recent years have occurred due to changes in surgical tactics (emphasis on functional status rather total resection), improvement of equipment for adjustment of surgical approach (MRI, intraoperative monitoring, intraoperative ultrasound), more accurate and effective adjuvant therapy contributing to preoperative shrinkage of tumor and preservation of functionally important areas.

{"title":"[Surgical treatment of intramedullary spinal cord tumors: a systematic review].","authors":"N A Konovalov, R A Onoprienko, S V Kaprovoy, E S Brinyuk, B A Zakirov, Yu M Poluektov, S V Ivanov, M O Kudymets, N O Ilyinsky","doi":"10.17116/neiro202589011103","DOIUrl":"https://doi.org/10.17116/neiro202589011103","url":null,"abstract":"<p><strong>Background: </strong>Intramedullary spinal cord tumors are a rare group of central nervous system tumors with special treatment approaches. The main problems are related to optimal time of surgery, invasiveness and recurrence of tumor.</p><p><strong>Objective: </strong>To review available literature data on the treatment of intramedullary spinal cord tumors, to summarize the main achievements and changes in treatment strategy over the past 5 years.</p><p><strong>Material and methods: </strong>We reviewed Russian- and English-language literature on the treatment of intramedullary spinal cord tumors over the past five years. The studies were selected in accordance with PRISMA recommendations.</p><p><strong>Results: </strong>We analyzed literature data in the PubMed, eLibrary, Cochrane and Medline databases over the last 5 years. The studies were selected taking into account the relevance and quality of researches.</p><p><strong>Conclusion: </strong>Large-scale studies are rare due to rarity of intramedullary spinal cord tumors. The main changes in surgery for intramedullary spinal cord tumors in recent years have occurred due to changes in surgical tactics (emphasis on functional status rather total resection), improvement of equipment for adjustment of surgical approach (MRI, intraoperative monitoring, intraoperative ultrasound), more accurate and effective adjuvant therapy contributing to preoperative shrinkage of tumor and preservation of functionally important areas.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":"89 1","pages":"103-108"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Augmented reality as a method of neuronavigation in microsurgical treatment of cerebrovascular diseases: description of the method and clinical experience].
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/neiro20258901137
A N Konovalov, D N Okishev, Yu V Pilipenko, Sh Sh Eliava, A A Artemiev, V M Ivanov, A Yu Smirnov, S V Strelkov

Augmented reality (AR) is a promising area in microsurgical treatment of cerebrovascular pathologies that can significantly facilitate preoperative planning and intraoperative understanding of anatomy.

Objective: To describe AR-assisted neuronavigation in microsurgical treatment of intracranial aneurysms, arteriovenous malformations and cavernomas; to evaluate accuracy and applicability of AR-assisted neuronavigation.

Material and methods: The study involved 22 patients with cerebral aneurysms, arteriovenous and cavernous malformations. Microsoft Hololens 2 HMD glasses and «Medgital» software for AR navigation were used. Accuracy of registration (TRE and FRE) and time for preoperative preparation were evaluated.

Results. mean: TRE when using QR code was 0.6±0.2 cm, when combining through craniometric points - 1.4±0.6 cm. Time for preoperative image processing was 24.7±5.1 minutes, application setup in the operating theatre - 1.6±0.2 minutes. Combination using QR code provided higher accuracy of registration compared to craniometric points. AR-assisted navigation improved visualization and planning of surgeries for aneurysms, arteriovenous malformations, microvascular anastomoses and cavernous angiomas.

Conclusion: AR-assisted navigation is an innovative method with specific advantages that can potentially improve microsurgical treatment of cerebrovascular diseases. Further research is needed to confirm these findings and develop AR technology in neurosurgery.

{"title":"[Augmented reality as a method of neuronavigation in microsurgical treatment of cerebrovascular diseases: description of the method and clinical experience].","authors":"A N Konovalov, D N Okishev, Yu V Pilipenko, Sh Sh Eliava, A A Artemiev, V M Ivanov, A Yu Smirnov, S V Strelkov","doi":"10.17116/neiro20258901137","DOIUrl":"https://doi.org/10.17116/neiro20258901137","url":null,"abstract":"<p><p>Augmented reality (AR) is a promising area in microsurgical treatment of cerebrovascular pathologies that can significantly facilitate preoperative planning and intraoperative understanding of anatomy.</p><p><strong>Objective: </strong>To describe AR-assisted neuronavigation in microsurgical treatment of intracranial aneurysms, arteriovenous malformations and cavernomas; to evaluate accuracy and applicability of AR-assisted neuronavigation.</p><p><strong>Material and methods: </strong>The study involved 22 patients with cerebral aneurysms, arteriovenous and cavernous malformations. Microsoft Hololens 2 HMD glasses and «Medgital» software for AR navigation were used. Accuracy of registration (TRE and FRE) and time for preoperative preparation were evaluated.</p><p><strong>Results. mean: </strong>TRE when using QR code was 0.6±0.2 cm, when combining through craniometric points - 1.4±0.6 cm. Time for preoperative image processing was 24.7±5.1 minutes, application setup in the operating theatre - 1.6±0.2 minutes. Combination using QR code provided higher accuracy of registration compared to craniometric points. AR-assisted navigation improved visualization and planning of surgeries for aneurysms, arteriovenous malformations, microvascular anastomoses and cavernous angiomas.</p><p><strong>Conclusion: </strong>AR-assisted navigation is an innovative method with specific advantages that can potentially improve microsurgical treatment of cerebrovascular diseases. Further research is needed to confirm these findings and develop AR technology in neurosurgery.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":"89 1","pages":"37-45"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Continuous monitoring of somatosensory evoked potentials following spinothalamic tract stimulation in brainstem and spinal cord surgery: case report and literature review].
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/neiro20258901194
K N Lapteva, A V Gavryushin

Background: The primary objective of neurosurgical intervention for central nervous system tumors is a balance between optimal tumor resection and minimal postoperative neurological impairment. Intraoperative neurophysiological monitoring is essential in safeguarding somatosensory tracts during surgery. Virtually the only tool for continuous monitoring of sensory pathways is registration of peripheral somatosensory evoked potentials (SSEPs). However, this method has some limitations.

Objective: To increase the quality of intraoperative SSEP monitoring in surgical treatment of brainstem and spinal cord tumors.

Material and methods: To ensure continuous monitoring of sensory pathway function in brainstem and spinal cord surgery, we modified the method for monitoring of SSEPs. Unlike standard technique, we placed two-contact electrode for stimulation either in the area of the bottom of the fourth ventricle or on posterior surface of the spinal cord along the midline. This allows us to stimulate pontine tegmentum or posterior columns of spinal cord.

Results: We demonstrated the feasibility of this method in 2 cases.

Conclusion: The advantage of this method is possible brainstem or spinal cord stimulation reducing the chain of somatosensory tract that is valuable to neutralize the effect of anesthesia on significance of neurophysiological data.

{"title":"[Continuous monitoring of somatosensory evoked potentials following spinothalamic tract stimulation in brainstem and spinal cord surgery: case report and literature review].","authors":"K N Lapteva, A V Gavryushin","doi":"10.17116/neiro20258901194","DOIUrl":"https://doi.org/10.17116/neiro20258901194","url":null,"abstract":"<p><strong>Background: </strong>The primary objective of neurosurgical intervention for central nervous system tumors is a balance between optimal tumor resection and minimal postoperative neurological impairment. Intraoperative neurophysiological monitoring is essential in safeguarding somatosensory tracts during surgery. Virtually the only tool for continuous monitoring of sensory pathways is registration of peripheral somatosensory evoked potentials (SSEPs). However, this method has some limitations.</p><p><strong>Objective: </strong>To increase the quality of intraoperative SSEP monitoring in surgical treatment of brainstem and spinal cord tumors.</p><p><strong>Material and methods: </strong>To ensure continuous monitoring of sensory pathway function in brainstem and spinal cord surgery, we modified the method for monitoring of SSEPs. Unlike standard technique, we placed two-contact electrode for stimulation either in the area of the bottom of the fourth ventricle or on posterior surface of the spinal cord along the midline. This allows us to stimulate pontine tegmentum or posterior columns of spinal cord.</p><p><strong>Results: </strong>We demonstrated the feasibility of this method in 2 cases.</p><p><strong>Conclusion: </strong>The advantage of this method is possible brainstem or spinal cord stimulation reducing the chain of somatosensory tract that is valuable to neutralize the effect of anesthesia on significance of neurophysiological data.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":"89 1","pages":"94-102"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Neuroimaging predictors of favorable outcomes after shunting procedures in patients with Hakim-Adams syndrome: a pilot prospective randomized trial].
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/neiro20258901168
A V Stanishevskiy, G V Gavrilov, B G Adleyba, M N Radkov, D V Svistov, I D Sukhinov

Higher effectiveness of cerebrospinal fluid shunting procedures is still an unresolved issue in the treatment of idiopathic normal pressure hydrocephalus. Thus, over 15% of patients do not experience symptom regression in postoperative period. In recent years, several MRI predictors have been actively investigated to forecast the outcomes of cerebrospinal fluid shunting procedures. We have previously introduced a prognostic model for comprehensive evaluation of MRI data facilitating identification of patients likely to benefit from surgical intervention.

Objective: To evaluate diagnostic properties of MRI data comprehensive assessment model compared to traditional invasive diagnostic method (spinal tap test) in prospective randomized trial.

Material and methods: MRI data and postoperative outcomes in patients diagnosed with idiopathic normal pressure hydrocephalus who underwent ventriculoperitoneal shunting between September 2022 and April 2024 were analyzed in prospective randomized study. In the study group, surgical decisions were based on MRI data, while the control group followed an algorithm incorporating invasive diagnostic method (spinal tap-test). Ventriculoperitoneal shunting with constant-pressure valve implantation was performed in all patients selected for surgery.

Results: The study included 54 patients (25 ones in the study group and 29 ones in the control group). Surgery was performed in 21 and 20 patients, respectively. We found no advantages of invasive diagnostic methods over comprehensive assessment of MRI data in predicting the effectiveness of surgical treatment.

Conclusion: Comprehensive assessment of MRI findings allows for avoiding invasive diagnostic procedures in decision-making on cerebrospinal fluid shunting surgery in some patients with idiopathic normal pressure hydrocephalus.

{"title":"[Neuroimaging predictors of favorable outcomes after shunting procedures in patients with Hakim-Adams syndrome: a pilot prospective randomized trial].","authors":"A V Stanishevskiy, G V Gavrilov, B G Adleyba, M N Radkov, D V Svistov, I D Sukhinov","doi":"10.17116/neiro20258901168","DOIUrl":"https://doi.org/10.17116/neiro20258901168","url":null,"abstract":"<p><p>Higher effectiveness of cerebrospinal fluid shunting procedures is still an unresolved issue in the treatment of idiopathic normal pressure hydrocephalus. Thus, over 15% of patients do not experience symptom regression in postoperative period. In recent years, several MRI predictors have been actively investigated to forecast the outcomes of cerebrospinal fluid shunting procedures. We have previously introduced a prognostic model for comprehensive evaluation of MRI data facilitating identification of patients likely to benefit from surgical intervention.</p><p><strong>Objective: </strong>To evaluate diagnostic properties of MRI data comprehensive assessment model compared to traditional invasive diagnostic method (spinal tap test) in prospective randomized trial.</p><p><strong>Material and methods: </strong>MRI data and postoperative outcomes in patients diagnosed with idiopathic normal pressure hydrocephalus who underwent ventriculoperitoneal shunting between September 2022 and April 2024 were analyzed in prospective randomized study. In the study group, surgical decisions were based on MRI data, while the control group followed an algorithm incorporating invasive diagnostic method (spinal tap-test). Ventriculoperitoneal shunting with constant-pressure valve implantation was performed in all patients selected for surgery.</p><p><strong>Results: </strong>The study included 54 patients (25 ones in the study group and 29 ones in the control group). Surgery was performed in 21 and 20 patients, respectively. We found no advantages of invasive diagnostic methods over comprehensive assessment of MRI data in predicting the effectiveness of surgical treatment.</p><p><strong>Conclusion: </strong>Comprehensive assessment of MRI findings allows for avoiding invasive diagnostic procedures in decision-making on cerebrospinal fluid shunting surgery in some patients with idiopathic normal pressure hydrocephalus.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":"89 1","pages":"68-74"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparative analysis of combined treatment methods for patients with single brain lesions]. [单一脑损伤患者的综合治疗方法比较分析]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/neiro20248804113
M Yu Ostapenko, V A Lukshin, D Yu Usachev, A V Golanov, E R Vetlova, A A Durgaryan, N G Kobyakov

Primary brain metastases are common in oncology. Preoperative stereotactic radiosurgery followed by surgical resection is a perspective approach.

Objective: To evaluate own experience of preoperative radiosurgery followed by surgical resection (RS+S) of metastasis regarding local control, leptomeningeal progression, surgical and radiation-induced complications; to compare treatment outcomes with surgical resection and subsequent radiotherapy (S+SRT).

Material and methods. a: Retrospective study included 66 patients with solitary brain metastasis. Two groups of patients were distinguished: group 1 (n=34) - postoperative irradiation, group 2 (n=32) - preoperative irradiation. The median age was 49.5 years (range 36-75).

Results: Local 3-, 6- and 12-month control among patients with postoperative irradiation was 88.2%, 79.4% and 42.9%, in the group of preoperative irradiation - 100%, 93.3% and 66.7%, respectively (p=0.021). Leptomeningeal progression developed in 11 patients (8 and 3 ones, respectively). The one-year survival rate was 73.5% and 84.4%, respectively (p=0.33). Long-term surgical and radiation-induced complications occurred in 12 (18.2%) patients.

Conclusion: Preoperative radiosurgery with subsequent resection provides higher local control and lower incidence of leptomeningeal progression in patients with single brain metastases.

原发性脑转移瘤在肿瘤学中很常见。术前立体定向放射外科手术后再进行手术切除是一种前景广阔的方法:评估术前放射外科手术后手术切除(RS+S)转移瘤的局部控制、脑白质进展、手术和放射引起的并发症等方面的经验;比较手术切除后放疗(S+SRT)的治疗效果。分为两组:第一组(34人)--术后照射,第二组(32人)--术前照射。中位年龄为 49.5 岁(36-75 岁不等):结果:术后照射患者3个月、6个月和12个月的局部控制率分别为88.2%、79.4%和42.9%,术前照射组分别为100%、93.3%和66.7%(P=0.021)。11例患者(分别为8例和3例)出现了脑膜病变。一年生存率分别为73.5%和84.4%(P=0.33)。12名患者(18.2%)出现了手术和放射引起的长期并发症:结论:对单发脑转移瘤患者来说,术前放射外科手术和随后的切除术可提供更高的局部控制率,并降低脑转移瘤进展的发生率。
{"title":"[Comparative analysis of combined treatment methods for patients with single brain lesions].","authors":"M Yu Ostapenko, V A Lukshin, D Yu Usachev, A V Golanov, E R Vetlova, A A Durgaryan, N G Kobyakov","doi":"10.17116/neiro20248804113","DOIUrl":"10.17116/neiro20248804113","url":null,"abstract":"<p><p>Primary brain metastases are common in oncology. Preoperative stereotactic radiosurgery followed by surgical resection is a perspective approach.</p><p><strong>Objective: </strong>To evaluate own experience of preoperative radiosurgery followed by surgical resection (RS+S) of metastasis regarding local control, leptomeningeal progression, surgical and radiation-induced complications; to compare treatment outcomes with surgical resection and subsequent radiotherapy (S+SRT).</p><p><strong>Material and methods. a: </strong>Retrospective study included 66 patients with solitary brain metastasis. Two groups of patients were distinguished: group 1 (<i>n</i>=34) - postoperative irradiation, group 2 (<i>n</i>=32) - preoperative irradiation. The median age was 49.5 years (range 36-75).</p><p><strong>Results: </strong>Local 3-, 6- and 12-month control among patients with postoperative irradiation was 88.2%, 79.4% and 42.9%, in the group of preoperative irradiation - 100%, 93.3% and 66.7%, respectively (<i>p</i>=0.021). Leptomeningeal progression developed in 11 patients (8 and 3 ones, respectively). The one-year survival rate was 73.5% and 84.4%, respectively (<i>p</i>=0.33). Long-term surgical and radiation-induced complications occurred in 12 (18.2%) patients.</p><p><strong>Conclusion: </strong>Preoperative radiosurgery with subsequent resection provides higher local control and lower incidence of leptomeningeal progression in patients with single brain metastases.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":"88 4","pages":"13-21"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142018875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Choice of fractionation regimen for Grade IV gliomas depending on rapid early progression]. [IV级胶质瘤分化方案的选择取决于早期病情的快速进展]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/neiro20248805123
A S Chuguev, T M Kobyletskaya, V A Gerasimov, A A Belikova, A D Kaprin, P V Datsenko

Objective: To investigate the effect of two fractionation regimens on survival in patients with Grade IV gliomas depending on rapid early progression (REP).

Material and methods: Fractionation with prescribed doses of 2 and 3 Gy was alternately used in 140 patients with morphologically confirmed Grade IV glioma using a pairwise modeling strategy.

Results: REP was diagnosed in 60 (42.9%) out of 140 patients with Grade IV gliomas and 55 (45.5%) out of 121 patients with glioblastomas. Fatal outcome was observed in 111 (79.3%) patients, 99 (70.7%) ones died from progression of glioma. In case of no REP, the median overall survival as of December 2023 was 32.20 (95% CI 25.7-38.7) months, with REP - only 16.03 (95% CI 13.5-18.6) months (p<0.0001). Median survival was slightly lower in patients with glioblastoma - 28.2 and 16.5 months, respectively (p<0.0001).

In patients with Grade IV gliomas and no REP, 3 Gy (n=40) fractionation regimen was followed by median overall survival 44.98 (95% Cl 15.3-74.6) months, 2 Gy (n=40) - 20.99 (95% CI 9.2-32.7) months (p=0.027). In case of glioblastoma, differences between fractionation regimes lose significance - medians 33.7 and 19.7 months, respectively (p=0.081). According to multivariate analysis, 3 Gy fractionation regimen is more effective than standard radiotherapy (p=0.009) in patients without REP, while significance of isoeffective doses <59.5Gy≥ is slightly lower (p=0.020). Radiotherapy on the background of temozolomide is equally important (p=0.007).

In patients with grade 4 gliomas and REP, 3 Gy (n=30) fractionation regimen was followed by median overall survival 17.18 (95% CI 14.2-20.2) months, 2 Gy (n=30) - 12.88 (95% CI 5.4-20.3) months (p=0.849). In case of glioblastoma, Cox model classification matrix looks as follows: fractionation variant (p=0.423), isoeffective dose <59.5Gy≥ (p<0.0001), temozolomide during radiotherapy (p=0.701), functional status (p=0.485).

Conclusion: In patients with Grade IV gliomas and no REP, 3 Gy fractionation regimen has significant advantages over standard radiotherapy regarding overall survival. In case of more aggressive course of tumor (REP), higher single dose does not improve treatment outcomes. Isoeffective dose ≥59.5Gy is of great importance.

目的根据快速早期进展(REP)情况,研究两种分次治疗方案对IV级胶质瘤患者生存期的影响:采用配对建模策略,对140例形态学确诊的IV级胶质瘤患者交替使用规定剂量为2 Gy和3 Gy的分次治疗方案:140例IV级胶质瘤患者中有60例(42.9%)确诊为REP,121例胶质母细胞瘤患者中有55例(45.5%)确诊为REP。111例(79.3%)患者出现死亡,其中99例(70.7%)死于胶质瘤进展。在无 REP 的情况下,截至 2023 年 12 月的中位总生存期为 32.20(95% CI 25.7-38.7)个月,而有 REP 的情况下--仅为 16.03(95% CI 13.5-18.6)个月(pp.6)个月(pp在IV级胶质瘤且无REP的患者中,采用3 Gy(n=40)分期治疗方案后,中位总生存期为44.98(95% Cl 15.3-74.6)个月,2 Gy(n=40)-20.99(95% CI 9.2-32.7)个月(p=0.027)。就胶质母细胞瘤而言,不同分化方案之间的差异失去了意义--中位数分别为33.7个月和19.7个月(P=0.081)。根据多变量分析,在无 REP 的患者中,3 Gy 分次疗法比标准放疗更有效(p=0.009),而等效剂量的显著性 p=0.020)。在4级胶质瘤和REP患者中,3 Gy(n=30)分次方案的中位总生存期为17.18(95% CI 14.2-20.2)个月,2 Gy(n=30)-12.88(95% CI 5.4-20.3)个月(p=0.849)。对于胶质母细胞瘤,Cox模型分类矩阵如下:分型变异(P=0.423)、等效剂量(P=0.701)、功能状态(P=0.485):结论:对于 IV 级胶质瘤且无 REP 的患者,3 Gy 分次方案在总生存期方面比标准放疗有明显优势。结论:对于 IV 级胶质瘤且无 REP 的患者,3 Gy 分次方案在总生存期方面比标准放疗方案有明显优势。等效剂量≥59.5Gy非常重要。
{"title":"[Choice of fractionation regimen for Grade IV gliomas depending on rapid early progression].","authors":"A S Chuguev, T M Kobyletskaya, V A Gerasimov, A A Belikova, A D Kaprin, P V Datsenko","doi":"10.17116/neiro20248805123","DOIUrl":"https://doi.org/10.17116/neiro20248805123","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the effect of two fractionation regimens on survival in patients with Grade IV gliomas depending on rapid early progression (REP).</p><p><strong>Material and methods: </strong>Fractionation with prescribed doses of 2 and 3 Gy was alternately used in 140 patients with morphologically confirmed Grade IV glioma using a pairwise modeling strategy.</p><p><strong>Results: </strong>REP was diagnosed in 60 (42.9%) out of 140 patients with Grade IV gliomas and 55 (45.5%) out of 121 patients with glioblastomas. Fatal outcome was observed in 111 (79.3%) patients, 99 (70.7%) ones died from progression of glioma. In case of no REP, the median overall survival as of December 2023 was 32.20 (95% CI 25.7-38.7) months, with REP - only 16.03 (95% CI 13.5-18.6) months (<i>p</i><0.0001). Median survival was slightly lower in patients with glioblastoma - 28.2 and 16.5 months, respectively (<i>p</i><0.0001).</p><p><p>In patients with Grade IV gliomas and no REP, 3 Gy (<i>n</i>=40) fractionation regimen was followed by median overall survival 44.98 (95% Cl 15.3-74.6) months, 2 Gy (<i>n</i>=40) - 20.99 (95% CI 9.2-32.7) months (<i>p</i>=0.027). In case of glioblastoma, differences between fractionation regimes lose significance - medians 33.7 and 19.7 months, respectively (<i>p</i>=0.081). According to multivariate analysis, 3 Gy fractionation regimen is more effective than standard radiotherapy (<i>p</i>=0.009) in patients without REP, while significance of isoeffective doses <59.5Gy≥ is slightly lower (<i>p</i>=0.020). Radiotherapy on the background of temozolomide is equally important (<i>p</i>=0.007).</p><p><p>In patients with grade 4 gliomas and REP, 3 Gy (<i>n</i>=30) fractionation regimen was followed by median overall survival 17.18 (95% CI 14.2-20.2) months, 2 Gy (<i>n</i>=30) - 12.88 (95% CI 5.4-20.3) months (<i>p</i>=0.849). In case of glioblastoma, Cox model classification matrix looks as follows: fractionation variant (<i>p</i>=0.423), isoeffective dose <59.5Gy≥ (<i>p</i><0.0001), temozolomide during radiotherapy (<i>p</i>=0.701), functional status (<i>p</i>=0.485).</p><p><strong>Conclusion: </strong>In patients with Grade IV gliomas and no REP, 3 Gy fractionation regimen has significant advantages over standard radiotherapy regarding overall survival. In case of more aggressive course of tumor (REP), higher single dose does not improve treatment outcomes. Isoeffective dose ≥59.5Gy is of great importance.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":"88 5","pages":"23-29"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142476318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Focal cortical dysplasia: visual assessment of MRI and MR morphometry data]. [局灶性皮质发育不良:磁共振成像和磁共振形态测量数据的视觉评估]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/neiro20248803145
A M Shevchenko, E L Pogosbekyan, A I Batalov, A N Tyurina, L M Fadeeva, S B Agrba, I N Pronin

Objective: Assessing the diagnostic significance of MR morphometry in determining the localization of focal cortical dysplasias (FCD).

Material and methods: The study included 13 children after surgery for drug-resistant epilepsy caused by FCD type II and stable postoperative remission of seizures (Engel class IA, median follow-up 56 months). We analyzed the results of independent expert assessment of native MR data by three radiologists (HARNESS protocol) and MR morphometry data regarding accuracy of FCD localization. We considered 2 indicators, i.e. local cortical thickening and gray-white matter blurring.

Results: FCD detection rate was higher after MR morphometry compared to visual analysis of native MR data using the HARNESS protocol. MR morphometry also makes it possible to more often identify gray-white matter blurring as a sign often missed by radiologists (p<0.05).

Conclusion: MR morphometry is an additional non-invasive method for assessing the localization of FCD.

目的:评估磁共振形态学在确定局灶性皮质发育不良(FCD)定位方面的诊断意义:评估磁共振形态学在确定局灶性皮质发育不良(FCD)定位方面的诊断意义:研究对象包括13名因FCD II型引起的耐药性癫痫而接受手术治疗且术后癫痫发作稳定缓解(恩格尔分级IA,中位随访时间56个月)的患儿。我们分析了三位放射科专家对原始 MR 数据(HARNESS 协议)和 MR 形态测量数据进行独立专家评估后得出的有关 FCD 定位准确性的结果。我们考虑了两个指标,即局部皮质增厚和灰白色物质模糊:结果:与使用 HARNESS 协议对原始 MR 数据进行视觉分析相比,MR 形态测量法的 FCD 检测率更高。磁共振形态学还能更频繁地识别灰白色物质模糊,因为这是放射科医生经常忽略的一个征象(p结论:磁共振形态测量是评估 FCD 定位的另一种非侵入性方法。
{"title":"[Focal cortical dysplasia: visual assessment of MRI and MR morphometry data].","authors":"A M Shevchenko, E L Pogosbekyan, A I Batalov, A N Tyurina, L M Fadeeva, S B Agrba, I N Pronin","doi":"10.17116/neiro20248803145","DOIUrl":"https://doi.org/10.17116/neiro20248803145","url":null,"abstract":"<p><strong>Objective: </strong>Assessing the diagnostic significance of MR morphometry in determining the localization of focal cortical dysplasias (FCD).</p><p><strong>Material and methods: </strong>The study included 13 children after surgery for drug-resistant epilepsy caused by FCD type II and stable postoperative remission of seizures (Engel class IA, median follow-up 56 months). We analyzed the results of independent expert assessment of native MR data by three radiologists (HARNESS protocol) and MR morphometry data regarding accuracy of FCD localization. We considered 2 indicators, i.e. local cortical thickening and gray-white matter blurring.</p><p><strong>Results: </strong>FCD detection rate was higher after MR morphometry compared to visual analysis of native MR data using the HARNESS protocol. MR morphometry also makes it possible to more often identify gray-white matter blurring as a sign often missed by radiologists (<i>p</i><0.05).</p><p><strong>Conclusion: </strong>MR morphometry is an additional non-invasive method for assessing the localization of FCD.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":"88 3","pages":"45-51"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141331879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Giant pericranial sinus with extensive occipital calvarium defect]. [巨大颅周窦伴广泛枕骨钙质缺损]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/neiro20248806177
A V Semenov, A A Semenov, A E Makarova

Background: Giant non-traumatic and non-iatrogenic cranial vault defects are poorly studied due to their rarity. Therefore, diagnosis and analysis of their causes are difficult. In available literature, we found only 4 cases of giant pericranial sinus accompanied by extensive cranial vault defects.

Objective: To present a rare and difficult diagnostic case of cranial vault lesion with non-traumatic and non-iatrogenic extensive bone defect, as well as to propose treatment of this pathology.

The patient presented with complaints of a «growing» parietal-occipital cranial vault defect in November 2022. This defect occurred in childhood. A comprehensive examination including CT angiography of cerebral vessels was followed by surgical treatment (bone resection along skull defect edge with biopsy (aponeurosis, periosteum, bone) and subsequent closure with titanium plate). Postoperative period was uneventful. CT of the skull and brain, including angiography and sinusography, were performed. The follow-up period was more than 10 months with favorable outcome.

Considering anamnesis, clinical and additional diagnostic data, we established giant dominant-type true pericranial sinus.

背景:巨大的非外伤性和非医源性颅拱顶缺陷由于其罕见性而很少被研究。因此,诊断和分析其原因是困难的。在现有文献中,我们仅发现4例巨大颅周窦伴广泛颅拱顶缺损。目的:报道一例罕见、难诊断的颅拱顶病变伴非外伤性、非医源性广泛骨缺损的病例,并提出治疗方法。该患者于2022年11月提出“生长”的顶枕颅穹窿缺损的主诉。这种缺陷发生在儿童时期。手术治疗(沿颅骨缺损边缘行骨切除并活检(腱膜、骨膜、骨),随后用钛板缝合)。术后无意外。行颅脑CT检查,包括血管造影和脑窦造影。随访10个月以上,预后良好。考虑到记忆、临床和其他诊断资料,我们建立了巨大的优势型真颅周窦。
{"title":"[Giant pericranial sinus with extensive occipital calvarium defect].","authors":"A V Semenov, A A Semenov, A E Makarova","doi":"10.17116/neiro20248806177","DOIUrl":"10.17116/neiro20248806177","url":null,"abstract":"<p><strong>Background: </strong>Giant non-traumatic and non-iatrogenic cranial vault defects are poorly studied due to their rarity. Therefore, diagnosis and analysis of their causes are difficult. In available literature, we found only 4 cases of giant pericranial sinus accompanied by extensive cranial vault defects.</p><p><strong>Objective: </strong>To present a rare and difficult diagnostic case of cranial vault lesion with non-traumatic and non-iatrogenic extensive bone defect, as well as to propose treatment of this pathology.</p><p><p>The patient presented with complaints of a «growing» parietal-occipital cranial vault defect in November 2022. This defect occurred in childhood. A comprehensive examination including CT angiography of cerebral vessels was followed by surgical treatment (bone resection along skull defect edge with biopsy (aponeurosis, periosteum, bone) and subsequent closure with titanium plate). Postoperative period was uneventful. CT of the skull and brain, including angiography and sinusography, were performed. The follow-up period was more than 10 months with favorable outcome.</p><p><p>Considering anamnesis, clinical and additional diagnostic data, we established giant dominant-type true pericranial sinus.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":"88 6","pages":"77-87"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142819446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Intrascopic predictors of favorable outcomes after ventriculoperitoneal shunting in Hakim-Adams syndrome: a single-center retrospective non-randomized study]. [哈基姆-亚当斯综合征脑室腹腔分流术后良好预后的筋膜内预测因素:一项单中心回顾性非随机研究]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/neiro20248805160
A V Stanishevskiy, G V Gavrilov, A V Lebedenko, B G Adleyba, M N Radkov, D V Svistov, V Yu Cherebillo

The main feature of idiopathic normal pressure hydrocephalus is reversible clinical manifestations after timely ventriculoperitoneal shunting. However, the effectiveness of such interventions does not exceed 85%. Invasive diagnostic methods are used to select candidates for surgery. At the same time, literature data indicate neuroimaging symptoms predicting postoperative outcomes without invasive examination.

Objective: To identify intrascopic predictors of favorable outcomes after ventriculoperitoneal shunting in Hakim-Adams syndrome; to present a model for evaluating MRI data and selecting candidates for surgery.

Material and methods: A single-center retrospective non-randomized study enrolled head MRI data in patients with idiopathic normal-pressure hydrocephalus who underwent ventriculoperitoneal shunting between September 2020 and March 2022. There were 34 patients including 15 ones in the main group (significant improvement after surgery) and 19 ones in the control group. We analyzed quantitative neuroimaging features: ventriculocranial indices, DESH syndrome (DESH score), angle of corpus callosum at the level of anterior and posterior commissures, dimensions of temporal horns of lateral ventricles, the number of lacunar infarcts in basal ganglia and white matter of hemispheres.

Results: We identified the most significant predictors of favorable outcomes after ventriculoperitoneal shunting: Evans index, indexed longitudinal size of lateral ventricles, angle of corpus callosum (at the level of anterior and posterior commissures) and DESH score. We created a classification model using discriminant analysis. This model allows us to predict the outcomes after ventriculoperitoneal shunting.

Conclusion: A comprehensive assessment of intrascopic symptoms allows us to predict the outcomes after ventriculoperitoneal shunting in patients with Hakim-Adams syndrome. In the future, we can avoid invasive diagnostic manipulations in some patients.

特发性正常压力脑积水的主要特征是在及时进行脑室腹腔分流后临床表现可逆。然而,此类干预措施的有效率不超过 85%。在选择手术对象时采用了侵入性诊断方法。同时,文献数据显示神经影像学症状可预测术后结果,而无需进行侵入性检查:目的:确定哈基姆-亚当斯综合征脑室腹腔分流术后良好预后的血管内预测因素;提出评估核磁共振成像数据和选择手术候选者的模型:一项单中心回顾性非随机研究收集了2020年9月至2022年3月期间接受脑室腹腔分流术的特发性正常压力脑积水患者的头部MRI数据。34名患者中包括15名主要组患者(术后病情明显好转)和19名对照组患者。我们分析了定量神经影像学特征:脑室颅指数、DESH综合征(DESH评分)、胼胝体前后突角度、侧脑室颞角尺寸、基底节和半球白质腔隙性梗死数量:我们确定了脑室腹腔分流术后最重要的预后因素:结果:我们确定了脑室腹腔分流术后最重要的预后因素:埃文斯指数、侧脑室纵向大小指数、胼胝体角度(前后胼胝体水平)和DESH评分。我们利用判别分析建立了一个分类模型。通过该模型,我们可以预测脑室腹腔分流术后的结果:结论:通过对血管内症状的综合评估,我们可以预测哈基姆-亚当斯综合征患者脑室腹腔分流术后的预后。今后,我们可以避免对部分患者进行侵入性诊断操作。
{"title":"[Intrascopic predictors of favorable outcomes after ventriculoperitoneal shunting in Hakim-Adams syndrome: a single-center retrospective non-randomized study].","authors":"A V Stanishevskiy, G V Gavrilov, A V Lebedenko, B G Adleyba, M N Radkov, D V Svistov, V Yu Cherebillo","doi":"10.17116/neiro20248805160","DOIUrl":"https://doi.org/10.17116/neiro20248805160","url":null,"abstract":"<p><p>The main feature of idiopathic normal pressure hydrocephalus is reversible clinical manifestations after timely ventriculoperitoneal shunting. However, the effectiveness of such interventions does not exceed 85%. Invasive diagnostic methods are used to select candidates for surgery. At the same time, literature data indicate neuroimaging symptoms predicting postoperative outcomes without invasive examination.</p><p><strong>Objective: </strong>To identify intrascopic predictors of favorable outcomes after ventriculoperitoneal shunting in Hakim-Adams syndrome; to present a model for evaluating MRI data and selecting candidates for surgery.</p><p><strong>Material and methods: </strong>A single-center retrospective non-randomized study enrolled head MRI data in patients with idiopathic normal-pressure hydrocephalus who underwent ventriculoperitoneal shunting between September 2020 and March 2022. There were 34 patients including 15 ones in the main group (significant improvement after surgery) and 19 ones in the control group. We analyzed quantitative neuroimaging features: ventriculocranial indices, DESH syndrome (DESH score), angle of corpus callosum at the level of anterior and posterior commissures, dimensions of temporal horns of lateral ventricles, the number of lacunar infarcts in basal ganglia and white matter of hemispheres.</p><p><strong>Results: </strong>We identified the most significant predictors of favorable outcomes after ventriculoperitoneal shunting: Evans index, indexed longitudinal size of lateral ventricles, angle of corpus callosum (at the level of anterior and posterior commissures) and DESH score. We created a classification model using discriminant analysis. This model allows us to predict the outcomes after ventriculoperitoneal shunting.</p><p><strong>Conclusion: </strong>A comprehensive assessment of intrascopic symptoms allows us to predict the outcomes after ventriculoperitoneal shunting in patients with Hakim-Adams syndrome. In the future, we can avoid invasive diagnostic manipulations in some patients.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":"88 5","pages":"60-68"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142476325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1